Author

A. Martinez-Moreno

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:flow cytometry· 1

Frequent Co-Authors

A. Naranjo-Lucena· 1 shared B. Silva-Santos· 1 shared D. A. Niedziela· 1 shared D. E. MacHugh· 1 shared D. Sanchez Martinez· 1 shared D. V. Correia· 1 shared F. Gutierrez-Aguera· 1 shared G. Mulcahy· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. Naranjo-Lucena

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivMar 15, 2022

Generation and proof-of-concept for allogeneic CD123 CAR-Delta One T (DOT) cells in Acute Myeloid Leukemia

D. Sanchez Martinez, N. Tirado, S. Mensurado…·P. Menendez

This study generates and pre-clinically validates CD123-targeted CAR-DOTs for relapsed/refractory AML, showing robust cytotoxicity and long-term persistence with IL-15 support.

DOI 10.1136/jitc-2022-005400

humanCITE-seq

𝕏 PostBluesky

ImmunologybioRxivJun 21, 2021

Timing of transcriptomic peripheral blood mononuclear cell responses of sheep to Fasciola hepatica infection differs from those of cattle, reflecting different disease phenotypes

D. A. Niedziela, A. Naranjo-Lucena, V. Molina-Hernandez…·G. Mulcahy

This study compares the transcriptomic responses of sheep and cattle PBMC to Fasciola hepatica infection, finding differences in gene expression and pathway activation that reflect distinct disease outcomes.

DOI 10.3389/fimmu.2021.729217

bulk RNA-seqstatistical model

𝕏 PostBluesky